How has been the historical performance of Bayer CropSci.?
Bayer CropSci has demonstrated strong historical growth in net sales, increasing from 3,167.30 Cr in Mar'19 to 5,473.40 Cr in Mar'25, though recent declines in operating income and profit metrics indicate challenges in maintaining profitability, with EPS falling from 168.86 in Mar'23 to 126.5 in Mar'25. Overall, while the company has shown robust performance, strategic adjustments may be necessary to sustain growth.
Answer:The historical performance of Bayer CropSci shows a steady increase in net sales and operating income over the years, with net sales rising from 3,167.30 Cr in Mar'19 to 5,473.40 Cr in Mar'25. Operating profit (PBDIT) also demonstrated growth, peaking at 1,035.00 Cr in Mar'24 before declining to 809.30 Cr in Mar'25. The profit before tax followed a similar trend, reaching a high of 990.10 Cr in Mar'23, then decreasing to 707.40 Cr in Mar'25. Despite fluctuations in profit after tax, which was 568.00 Cr in Mar'25 compared to 758.20 Cr in Mar'23, the overall trajectory indicates a robust performance. The earnings per share (EPS) saw a decline from 168.86 in Mar'23 to 126.5 in Mar'25, reflecting the challenges faced in the latest fiscal year. Breakdown:
Bayer CropSci's financial metrics reveal a consistent upward trend in net sales, which increased from 3,167.30 Cr in Mar'19 to 5,473.40 Cr in Mar'25, indicating strong revenue growth. Operating income followed suit, rising from 534.20 Cr in Mar'19 to a peak of 1,035.00 Cr in Mar'24, before dropping to 809.30 Cr in Mar'25. Profit before tax also showed a similar pattern, climbing from 480.00 Cr in Mar'19 to 990.10 Cr in Mar'23, then declining to 707.40 Cr in Mar'25. Profit after tax fluctuated, reaching 568.00 Cr in Mar'25, down from 758.20 Cr in Mar'23. The earnings per share (EPS) decreased from 168.86 in Mar'23 to 126.5 in Mar'25, reflecting the challenges in maintaining profitability in the latest fiscal year. Overall, while Bayer CropSci has shown significant growth over the years, recent results indicate a need for strategic adjustments to sustain its performance.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
